Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» heartburn
heartburn
AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million
Forbes
Tue, 10/3/23 - 11:34 am
AstraZeneca
legal
kidney disease
heartburn
Nexium
Prilosec
Common Heartburn Drug Being Studied As Possible COVID-19 Treatment
BioSpace
Tue, 04/28/20 - 10:37 am
COVID-19
heartburn
Pepcid
famotidine
Can reformulation of an AstraZeneca castoff rival Takeda's new heartburn drug? Here's a $26M bet on yes
Endpoints
Wed, 03/4/20 - 07:55 pm
Cinclus Pharma
AstraZeneca
heartburn
linaprazan
Takeda
acid reflux
FDA to Heartburn Drug Manufacturers: Do Not Release Lots if NDMA is Above Acceptable Levels
RAPS.org
Thu, 12/5/19 - 11:39 pm
FDA
NDMA
Zantac
heartburn
PPI Problems: Heartburn Drugs Associated with Increased Risk of Death
Xtalks
Wed, 07/5/17 - 07:19 pm
PPIs
proton pump inhibitors
heartburn
GERD
Nexium
Some heartburn drugs linked to increased risk of heart attack
Medical Marketing and Media
Fri, 06/12/15 - 10:47 am
heartburn
heart attack
Nexium
Prilosec
Prevacid
AstraZeneca
Takeda
P&G
proton pump inhibitors
Impax files for approval of generic heartburn drug
Yahoo/AP
Mon, 04/4/11 - 10:50 pm
generics
heartburn
Impax
Takeda
Dexilant
XenoPort announces mid-stage drug study result
Yahoo/AP
Mon, 03/21/11 - 11:32 am
XenoPort
arbaclofen placarbil
heartburn
Teva gets FDA approval for generic Prevacid
Yahoo/AP
Tue, 11/10/09 - 07:26 pm
generics
Prevacid
heartburn
Teva Pharmaceuticals
Santarus: FDA sets action date on heartburn drug
Marketwatch
Tue, 06/23/09 - 07:40 am
FDA
Santarus
heartburn
Zegerid
Mixing Plavix, Heartburn Drugs Seen as Risky
WSJ Online
Thu, 05/7/09 - 06:22 am
Plavix
heartburn
PPIs
Nexium
FDA declines to approve OTC heartburn drug: Santarus
Reuters
Tue, 01/13/09 - 08:27 am
FDA
heartburn
Santarus